Dr. Dinesh Jothimani

Dr. Dinesh Jothimani

Senior Consultant - Liver Transplant Physician (Hepato Pancreato Billiary & Liver Transplant)
Registration no:
Institute of Liver, Pancreas Diseases & Transplant
Global Health City, Chennai

  • Education
  • Experience
  • Credentials

Qualification: MBBS, MRCP (U.K), CCT (Hepatology, Gastroenterology & General Medicine)

Bachelors Degree: MBBS (2000), Madras Medical College & Government General Hospital, Dr MGR Medical University, Madras (Chennai), India

Master Degree: MRCP (UK) 2004, The Royal College of Physicians, UK CCT (Hepatology, Gastroenterology & General Medicine) West Midlands Deanery, 2010

Experience:

  • Consultant Hepatologist, MIOT Advanced Center for Gastrointestinal and Liver Diseases MIOT Hospitals, Chennai, India
  • Consultant Hepatologist, University Hospitals of Coventry & Warwickshire
  • Senior Registrar Hepatology, Derriford Hospitals, Plymouth, UK
  • Hepatology Fellowship, Brisbane Australia
  • Specialist Registrar Rotation Hepatology and Gastroenterology/G(I)M. West Midlands Deanery, UK

Special Interest: Acute Liver Failure, Liver Transplantation, Viral Hepatitis, Autoimmune Hepatitis & ERCP

Membership:

  • Indian Association for the Study of Liver (INASL) - 2011
  • Indian Society of Gastroenterology (ISG) 2011
  • General Medical Council (GMC) Specialist Register for Hepatology, Gastroenterology & General Medicine, since 2010
  • European Association of Study of Liver (EASL), since 2009
  • British association of study of Liver (BASL), since 2009
  • Royal College of Physicians (RCP), London, since 2004

Certification: Certificate of Completion of Training (CCT) in Hepatology, Gastroenterology & General Medicine

Publication:

  • Macrophage secretory products induce an inflammatory phenotype in hepatocytes. Michelle Melino, Victoria L Gadd, Dinesh Jothimani, Andrew D Clouston, Julie R Jonsson, Elizabeth E Powell. World J Gastroenterol 2012 April 21; 18(15): 1732-1744
  • Non-invasive assessment of fibrosis in liver grafts due to hepatitis C recurrence. TJ Cross, D Jothimani, M Heneghan, P Harrison Clinical Transplantation 2011 May;25(3):345-51
  • Treatment of Autoimmune hepatitis- a review of current and evolving therapies. D Jothimani, M Cramp, J Mitchell, TJ Cross. J Gastroenterol Hepatol. 2010 Nov 15. doi: 10.1111/j.1440-1746.2010.06579
  • Re: Early use of TIPS in cirrhotic patients with variceal bleeding - Letter D Jothimani, TJS Cross. N Engl J Med. 2010; 363: 1375-76
  • Re: outcome of recurrent hepatitis C virus after liver transplantation in a randomized trial of monotherapy versus triple therapy-Letter. D Jothimani, TJ Cross. Liver Transpl. 2010 May;16(5):68
  • Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided stage of fibrosis is considered. McPherson S, Jonsson J..Jothimani D…Powell E J Hepatol. 2009 Aug;51(2):389-9
  • An unusual case of gastric erosions. Jothimani D, Zanetto U, R Owen, P Wilson. Gut. 2009 Dec;58(12):1669, 1708
  • Effect of ethnicity on the presentation and management of oesophageal and gastric cancers- A UK perspective. Sadler G, Jothimani D, Zanetto U, M Anderson. Eur J Gastroenterol Hepatol. 2009 Sep;21(9):996-100
  • Long term immunosuppression for prevention of non-viral disease recurrence. Neuberger J, Jothimani D. Transplantation Proc May 2005; 37(4):1671-4.